Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.3 EUR | +1.91% |
|
+14.44% | -5.85% |
06-18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
06-13 | Formycon Starts Clinical Trials of Keytruda Biosimilar Candidate for Skin Cancer Therapy | MT |
Analyst Reco.
- Stock Market
- Equities
- FYB Stock
- News Formycon AG
- Analyst Reco.